UTMD
Undervalued by 113.9% based on the discounted cash flow analysis.
Market cap | $189.83 Million |
---|---|
Enterprise Value | $107.47 Million |
Dividend Yield | $1.215 (2.07905544147844%) |
Earnings per Share | $3.96 |
Beta | 0.28 |
Outstanding Shares | 3,310,000 |
Return on Equity | - |
---|---|
Return on Assets | - |
Return on Invested Capital | - |
P/E Ratio | 14.93 |
---|---|
PEG | -64.54 |
Price to Sales | 5.24 |
Price to Book Ratio | 1.65 |
Enterprise Value to Revenue | 2.74 |
Enterprise Value to EBIT | 7.3 |
Enterprise Value to Net Income | 8 |
Total Debt to Enterprise | 0.01 |
Debt to Equity | 0.01 |
No data
No data
Utah Medical Products, Inc. with particular interest in health care for women and their babies, develops, manufactures and markets a broad range of disposable and reusable specialty medical devices recognized by clinicians in over a hund...